Standard BioTools receives Nasdaq deficiency notice for bid price below $1.00

STANDARD BIOTOOLS INC.

Closing bid price below $1.00 for 30 consecutive business days triggered the notice.
Company has 180 calendar days, until January 19, 2027, to regain compliance.
If eligible, may transfer to Nasdaq Capital Market for an additional 180-day cure period.
No immediate effect on trading of LAB common stock on Nasdaq.
Company intends to work toward compliance, e.g., via reverse stock split if needed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.